You have 9 free searches left this month | for more free features.

Hangzhou (1)

BCLC Stage C Hepatocellular Carcinoma (1)

Not yet recruiting (1)

phase 2 (1)

First Affiliated Hospital of Zhejiang University (1)

BeiGene (Beijing) Co., Ltd (1)

sorafenib (1)

tace (1)

tilelizumab (1)

drug (1)

procedure (1)

Other (1)

Interventional (1)

tilelizumab

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Hangzhou, Zhejiang, China

The First Affiliated Hospital, College of Medicine, Zhejiang Uni

Aug 10, 2021